American Vanguard Corporation (NYSE:AVD – Get Free Report) Director Patrick Gottschalk purchased 25,000 shares of the stock in a transaction dated Tuesday, May 19th. The shares were acquired at an average price of $2.70 per share, with a total value of $67,500.00. Following the completion of the acquisition, the director owned 191,705 shares in the company, valued at approximately $517,603.50. This trade represents a 15.00% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
American Vanguard Stock Performance
NYSE AVD opened at $2.87 on Friday. The stock has a market cap of $81.97 million, a PE ratio of -1.80 and a beta of 1.48. The company has a current ratio of 2.32, a quick ratio of 1.41 and a debt-to-equity ratio of 1.39. American Vanguard Corporation has a twelve month low of $2.05 and a twelve month high of $5.92. The stock has a fifty day simple moving average of $2.79 and a 200-day simple moving average of $3.93.
American Vanguard (NYSE:AVD – Get Free Report) last released its quarterly earnings results on Wednesday, May 6th. The basic materials company reported ($0.14) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.08). The business had revenue of $123.57 million for the quarter, compared to analysts’ expectations of $120.00 million. American Vanguard had a negative return on equity of 4.13% and a negative net margin of 8.71%.
Hedge Funds Weigh In On American Vanguard
Analyst Upgrades and Downgrades
Separately, Weiss Ratings cut American Vanguard from a “sell (d-)” rating to a “sell (e+)” rating in a report on Monday. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $12.00.
Check Out Our Latest Research Report on American Vanguard
About American Vanguard
American Vanguard Corporation (NYSE: AVD) is a developer, manufacturer and marketer of specialty chemical products for crop protection, turf and ornamental care, and public health pest control. Headquartered in Newport Beach, California, the company offers a portfolio of insecticides, herbicides, fungicides and rodenticides designed for use across agricultural, turf and urban pest management applications. Its research and development efforts focus on novel chemistries and formulation technologies that address emerging pest resistance and regulatory requirements.
The company’s product lines include emulsifiable concentrates, wettable powders, granular formulations, baits and liquid concentrates sold under proprietary brand names.
Recommended Stories
- Five stocks we like better than American Vanguard
- Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
- As Small-Cap Outperformance Continues, These 2 ETFs Provide Exposure
- Silicon Shake-Up: The AI Trade Is Moving Beyond NVIDIA
- The Silver Lining of Last Week’s Hims & Hers Earnings Miss
Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.
